Drug Trial Radar · NCT02148796
Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness
Last checked: Nov 19, 2026Latest source record: Jun 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
822
Actual
Start
Jan 1, 2017
Primary completion
Jan 30, 2026
Study completion Jan 30, 2026
Sponsor
- Lead sponsor
- University of ArizonaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 28, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 months, up to 18 months
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate if Broncho-Vaxom® given to high risk infants for 10 days, monthly, for two consecutive years can increase time to occurrence of the first episode of wheezing lower respiratory tract illness (WLRI) during a three year observation period off therapy.
Conditions
- Asthma
- Wheezing
Interventions
Broncho-Vaxom (BV)Drug
Active Ingredient: Lyophilised bacterial extract; Chemical Name: OM-85 BV; Strength: 3.5 mg; Excipients: bacterial extract, propyl gallate, sodium glutamate, mannitol, pregelatinised starch, magnesium stearate; Appearance: Blue and white capsule; Dosage Form: 3.5 mg capsule; Manufacturer: OM Pharma, Switzerland (OM stands for Omnia Medicamenta) Storage: Store in the original package
PlaceboOther
A placebo capsule will be used that will be indistinguishable from the active study drug.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The time to the occurrence of the first WLRI episode in the observation period while not receiving study drugTime frame: ages 30 to 42 months at the end of treatment; ages 66 to 78 months at completion
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Phoenix Children's Hospital
Phoenix, Arizona
University of Arizona
Tucson, Arizona
University of California San Francisco, Benioff Children's Hospital
Oakland, California
Children's National Health System
Washington D.C., District of Columbia
Emory University
Atlanta, Georgia
Boston Children's Hospital, Harvard University
Boston, Massachusetts
Washington University
St Louis, Missouri
Columbia University
New York, New York
University of North Carolina
Chapel Hill, North Carolina
Cincinnati Children's Hospital & Medical Center
Cincinnati, Ohio
University of Wisconsin
Madison, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.